FindMyKOL
Clinical trialNCT01790893UnknownPhase 1/PHASE2Interventional

Treatment for Presumed Ocular Histoplasmosis

SponsorJohn Kitchens, MDEnrollment40Ocular Histoplasmosis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to monitor safety outcomes for patients being treated with intravitreal aflibercept injections for choroidal neovascularization secondary to Presumed Ocular Histoplasmosis Syndrome.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Southeast Retina

    Augusta, Georgia, United States

    Dennis Marcus, MDHarinderjit Singh, MD
    Recruiting
  • Retina Associates of Kentucky

    Lexington, Kentucky, United States

    Andrew Moshfeghi, MDJohn W. Kitchens, MDRick Isernhagen, MDTom Stone, MDWilliam J Wood, MD
    Recruiting
  • Cincinnati Eye Institute

    Cincinnati, Ohio, United States

    Brian Toussaint, MDChristopher Riemann, MDDaniel Miller, MDMichael Petersen, MD, PhDRobert Foster, MDRobert Sisk, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Aflibercept →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2013
Primary completion
31 Aug 2014
Completion
31 Aug 2014
Last update posted
16 Jun 2014
Registered enrollment
40
Registry id
NCT01790893
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.